Author

Luca Bortolani

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Obesity at antiretroviral therapy initiation and long-term risk of cardiovascular disease, cancer, or death in people with HIV in Italy: a prospective cohort study

Summary Background Altered adipose tissue biology plays a key role in the development of cardiovascular disease (CVD) and cancer and contributes to mortality. We assessed the association between obesity in people with HIV (PWH) at antiretroviral therapy (ART) initiation and the risk of clinical events. Methods In this...

C. Mussini, A. Giacomelli, G. Lapadula et al. · EClinicalMedicine · 0 citations

Open access Aug 2026

Long-term treatment durability and safety after switching to bictegravir/emtricitabine/tenofovir alafenamide in real-world practice: a 144-week update from the BICTEL cohort.

BACKGROUND Real-world evidence on bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) beyond 96 weeks remains limited. We assessed treatment durability, tolerability and laboratory safety after switching to BIC/FTC/TAF through 144 weeks in routine HIV care. METHODS As of 30 March 2026, 180 participants enro...

Luca Bortolani, Riccardo Donà, Antonietta Impellizzeri et al. · International Journal of Ant... · 0 citations